ARLINGTON, Mass., May 23, 2022 (GLOBE NEWSWIRE) -- Kala Pharmaceuticals, Inc. (NASDAQ:KALA), a commercial-stage biopharmaceutical company focused on the discovery, development and commercialization of ...
KALA BIO, Inc. (NASDAQ: KALA) (“KALA ” or the “Company ”) today celebrated the landmark Executive Order signed by U.S. President Donald J. Trump on April 18, 2026. The Order directs the FDA to ...
Shares of Kala Pharmaceuticals surged Wednesday after the small biotechnology company announced a drug candidate for a rare eye disease. The Food and Drug Administration has accepted Kala's ...
Kala Bio announced that it is ready to ship its first commercial AI product, which is expected to transform the company’s operations and potentially the biotech industry. The product is set to launch ...
You may call it a close cousin of the nation's favourite sweet - Gulab Jamun, but the Kala Jaam or Kala Jamun deserves more attention and praise. These sugar dipped rounds made of khoya, and cottage ...
・A rescue financing and loan settlement halted an impending asset seizure after Oxford’s default. ・A two-stage preferred stock deal supplies up to $6 million to stabilize operations and restructure ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results